SONNET BIOTHERAPEUTICS HOLDI (SONN) Stock Analyst Ratings
NASDAQ:SONN - Nasdaq - US83548R4020 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to SONN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.4. This target is 1114.29% above the current price.
SONN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SONN.
In the previous month the buy percentage consensus was at a similar level.
SONN was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-23 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-16 | EF Hutton | Maintains | Buy -> Buy |
| 2024-02-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-11-27 | Ladenburg Thalmann | Initiate | Buy |
| 2023-08-16 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-06-26 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-05-11 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-04-19 | EF Hutton | Reiterate | Buy |
| 2023-04-19 | Chardan Capital | Maintains | Buy |
| 2023-02-15 | EF Hutton | Reiterate | Buy |
| 2022-12-19 | EF Hutton | Initiate | Buy |
| 2022-09-22 | Chardan Capital | Maintains | Buy |
| 2022-08-16 | Chardan Capital | Maintains | Buy |
| 2022-02-09 | BTIG | Maintains | Buy |
| 2021-12-20 | Chardan Capital | Maintains | Buy |
| 2021-12-16 | HC Wainwright & Co. | Initiate | Buy |
| 2021-09-15 | BTIG | Initiate | Buy |